PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net loss ($74.4m) ($92.2m) ($102.6m) ($84.1m) $29.4m ($181.2m) ($314.2m) ($306.7m) ($309.9m) ($546.4m)
Net Income (Loss) Attributable to Parent ($74.4m)
($92.2m) -23.95%
($102.6m) -11.25%
($84.1m) +17.97%
$29.4m +134.95%
($181.2m) -716.34%
($314.2m) -73.40%
($306.7m) +2.39%
($309.9m) -1.02%
($546.4m) -76.34%
Depreciation, Depletion and Amortization $3.9m $8.4m $7.2m $7.3m $6.4m $7.2m $9.5m $11.5m $13.8m $13.0m $17.6m
Amortization $8.3m $27.4m $369.4m $4.6m
Amortization of Debt Issuance Costs $532k $617k $0 $0
Amortization of Debt Issuance Costs and Discounts $1.2m $1.2m $1.0m $1.2m $129k $539k $640k ($7.4m) $0 $0
Amortization of Intangible Assets $400k $900k $6.2m $27.4m $369.4m
Amortization of right-of-use assets $2.7m $2.9m $4.0m $6.9m $6.8m $12.2m $4.0m
Accretion of discount and amortization of premium on marketable securities, net $97k $47k ($758k) ($913k) ($107k) $4.0m ($244k) ($12.8m) ($13.0m) ($4.4m)
Deferred Income Tax Expense (Benefit) ($93.6m) $0 ($11.4m) ($205k) ($546k) $0
Share-based Payment Arrangement, Noncash Expense $19.6m $20.4m $23.2m $16.4m $17.5m $73.4m $78.6m $72.1m $71.0m $41.7m $34.3m
Share-based Payment Arrangement, Expense $19.6m $20.4m $23.2m $16.4m $17.5m $80.7m $78.6m $72.1m $34.3m
Share-based compensation expense $19.6m $20.4m $23.2m $16.4m $17.5m $73.4m $78.6m $72.1m $71.0m $41.7m $34.3m
Goodwill and Intangible Asset Impairment $184.5m $15.0m
Goodwill, Impairment Loss $144.5m $0
Impairment charges $0 $0 $184.5m $15.0m
Other Nonoperating Income (Expense) $103k $516k $848k $1.0m $2.1m $93k $7.6m $32.7m $23.8m $14.8m
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable $6.2m $2.0m ($4.8m) $6.7m $1.6m $7.2m ($5.5m) $17.8m ($9.1m) $7.9m $1.2m
Accounts receivable, net ($6.2m) ($2.0m) $4.8m ($6.7m) ($1.6m) ($7.2m) $5.5m ($17.8m) $9.1m ($7.9m) $1.2m
Increase (Decrease) in Inventories $6.2m $8.4m ($3.6m) ($3.9m) $1.1m $12.4m $33.9m $13.8m $8.3m $1.4m ($12.0m)
Inventory Write-down $6.0m $10.6m $4.6m $9.6m
Inventory provision $527k $678k $6.0m $10.6m $4.6m $9.6m
Inventory, net ($6.2m) ($8.4m) $3.6m $3.9m ($1.1m) ($12.4m) ($33.9m) ($13.8m) ($8.3m) ($1.4m) ($12.0m)
Increase (Decrease) in Accounts Payable $3.4m $764k ($2.2m) $1.7m ($5.1m) $6.4m $1.0m $206k $1.4m $2.5m $4.1m
Accrued expenses $1.1m ($4.0m) $205k $419k $4.1m $15.3m ($3.7m) $13.1m ($26.3m) $3.2m $3.8m
Deferred revenue ($1.0m) $33k $2.1m $729k $25.7m ($3.7m) ($10.4m) ($2.1m) $101k
Prepaid expenses and other assets ($202k) $7.8m ($290k) ($523k) ($1.1m) ($1.0m) ($12.3m) ($9.0m) $2.2m $8.5m
Other liabilities $1.7m $880k ($505k) ($563k) $5.0m ($803k) $887k $2.4m ($4.6m) ($1.2m)
Net Cash Provided by (Used in) Operating Activities ($67.9m)
($67.5m) +0.61%
($66.4m) +1.61%
($78.3m) -17.89%
$19.5m +124.90%
($111.2m) -670.07%
($263.2m) -136.74%
($259.2m) +1.53%
($206.1m) +20.49%
($111.2m) +46.03%
($118.0m) -6.15%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $8.2m $10.4m $1.9m $2.8m $1.0m $5.9m $16.8m $8.8m $6.2m $2.7m ($12.4m)
Gain (Loss) on Disposition of Property Plant Equipment $1.3m $1.9m $1.9m ($194k) ($919k) ($54k) ($278k) ($7.0m) ($2.6m) ($1.6m)
Cash, Cash Equivalents, and Short-term Investments $62.9m
Payments to Acquire Investments $95.8m $86.3m $122.2m $57.7m $373.3m $988.0m $442.8m $756.6m $498.6m $216.9m ($156.5m)
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $65.9m $88.1m $83.2m $121.1m $153.6m $422.5m $575.8m $769.5m $594.0m $340.1m
Purchase of investments ($95.8m) ($86.3m) ($122.2m) ($57.7m) ($373.3m) ($988.0m) ($442.8m) ($756.6m) ($498.6m) ($216.9m) ($156.5m)
Sales of investments $23.3m $7.1m $2.4m $1.5m $1.4m $212.7m $0 $595k $34.9m $0
Maturities of investments $65.9m $88.1m $83.2m $121.1m $153.6m $422.5m $575.8m $769.5m $594.0m $340.1m
Payments to Acquire Businesses, Net of Cash Acquired $0 $0 $0
Net Cash Provided by (Used in) Investing Activities ($14.9m) ($1.5m) ($38.4m) $62.0m ($219.3m) ($678.5m) $116.1m $4.6m $124.0m $115.4m $120.9m
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt $0 $0 ($2.0m) $0 $0
Loss on extinguishment of debt $0 $0 $2.0m $0 $0
Gain on debt restructuring $0 $0 ($154.4m) $0
Payment of debt issuance costs $0 $0 ($7.4m) $0 $0
Proceeds from Issuance of Common Stock $7.7m $8.9m $9.7m $8.5m $46.4m $31.8m $11.2m $15.3m $0 $0 $0
Proceeds from issuance of common stock from equity plans $11.2m $15.3m $7.7m $3.4m $0
Issuance of common stock $0 $0 $86.9m $36.2m $0 $0
Proceeds from (Payments for) Other Financing Activities ($147k) $47k ($245k) $0 $0 ($628k) $1.7m
Net Cash Provided by (Used in) Financing Activities $65.9m
$68.8m +4.37%
$107.2m +55.77%
$26.5m -75.23%
$251.8m +848.62%
$1.2b +364.42%
$9.6m -99.18%
$108.9m +1031.69%
($43.0m) -139.48%
$3.4m +107.97%
$3.2m -7.79%
Net increase (decrease) in cash, cash equivalents, and restricted cash $52.0m $379.9m ($137.5m) ($145.7m) ($125.0m) $7.7m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $52.0m $379.9m ($137.5m) ($145.7m) ($125.0m) $7.7m $62.6m
Cash, cash equivalents, and restricted cash at beginning of period $21.3m $21.0m $23.3m $33.6m $85.9m $465.8m $328.3m $182.6m $57.6m $65.3m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23.3m $33.6m $85.9m $465.8m $328.3m $182.6m $57.6m $65.3m $62.6m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $1.8m $1.7m $1.4m $1.4m $491k $6.9m $14.0m $15.7m $14.8m $8.3m
Income Taxes Paid, Net $481k
Additional Financial Items
Gain (Loss) on Sale of Derivatives ($653k) $167k $16k
Goodwill $410.0m $410.0m $462.3m $317.8m $317.8m $0
Income Tax Expense (Benefit) ($93.6m) ($11.4m) $316k $318k
Interest Expense Nonoperating $13.4m $7.0m
Noncash Merger Related Costs $3.4m $0 $0
Operating Expenses $115.4m $124.4m $126.1m $135.1m $137.0m $269.3m $356.2m $387.2m $511.6m $599.6m
Revenue from Contract with Customer, Including Assessed Tax $78.6m $90.9m $78.9m $130.5m $128.3m $200.5m $154.0m $160.0m
Merger-related compensation expense $0 $0 $3.4m $0 $0
Change in fair value of contingent consideration $1.1m $2.4m $15.1m ($850k) ($18.7m)
Operating lease liabilities ($3.4m) ($3.8m) ($5.0m) ($7.7m) ($8.8m) ($11.9m) $723k
Contingent consideration liability $0 $0 ($14.9m) $0 $0
Purchase of intangible assets $0 ($179k) $0 $0 ($5.0m)
Cash paid for purchases of acquired entities, net of cash acquired ($319.8m) $0 ($102k) $0 $0
Payment of contingent consideration $0 $0 ($86.4m) $0 $0
Payments made in conjunction with convertible notes exchange $0 $0 $50.2m $0
Notes payable principal payoff ($4.5m) ($16.0m) ($361k) ($1.6m) ($1.8m) ($490k) $0
Cash and cash equivalents at end of period $16.8m $16.5m $18.8m $29.6m $81.6m $460.7m $325.1m $179.9m $55.4m $63.7m
Restricted cash at end of period $4.5m $4.5m $4.5m $4.0m $4.3m $5.1m $3.2m $2.7m $2.2m $1.6m
Right-of-use asset and liability additions and modifications $2.6m $0 $0 $18.3m $29.6m
Convertible notes exchange $0 $0 $441.0m $0 $0

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.